Latest On GW Pharmaceuticals plc (GWPH):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-07-22 14:46 EST | News | Jazz updates 2021 financial guidance to reflect impact of GW Pharma acquisition | N/A |  |
| 2021-05-06 04:37 EST | News | Jazz closes acquisition of GW Pharmaceuticals | N/A | |
| 2021-04-24 02:21 EST | News | GW Pharma shareholders approve $7.2B acquisition by Jazz | N/A | |
| 2021-04-20 17:01 EST | News | GW Pharma's Epidyolex OK'd in Europe for seizures due to rare genetic condition | N/A | |
| 2021-02-26 12:24 EST | News | European advisory group backs GW Pharma's Epidyolex in benign tumors | N/A | |
| 2021-02-26 12:24 EST | News | GW Pharma gets European nod on expanded label for Epidyolex | N/A | |
| 2021-02-24 01:36 EST | News | Jazz sees product revenues rise 14% in Q4 but adjusted net income falls nearly 10% | N/A | |
| 2021-02-17 21:42 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-17 13:09 EST | Earnings Estimate | An EPS average of $5.08 is estimated for the 2022 year. | Buy | |
| 2021-02-17 13:09 EST | Earnings Estimate | An EPS average of -$0.16 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-02-17 13:09 EST | Analyst Rating | The Analyst Target Price has increased from $200.4 to $204.9. | Neutral | |
| 2021-02-16 21:01 EST | News | GW Pharmaceuticals EPS misses by $0.02, beats on revenue | N/A | |
| 2021-02-11 18:25 EST | News | Cannabis craze sees marijuana names light up again | N/A | |
| 2021-02-11 09:34 EST | Analyst Rating | The Analyst Target Price has increased from $195.36 to $200.4. | Neutral | |
| 2021-02-10 09:30 EST | Analyst Rating | The Analyst Target Price has increased from $192.82 to $195.36. | Neutral | |
| 2021-02-07 03:52 EST | News | Marijuana as medicine: the other cannabinoid pharma players | N/A | |
| 2021-02-05 19:53 EST | News | Jazz Pharmaceuticals: GW Pharmaceuticals Acquisition Makes Sense | N/A | |
| 2021-02-05 09:48 EST | Analyst Rating | The Analyst Target Price has increased from $181.92 to $192.82. | Neutral | |
| 2021-02-04 13:53 EST | Analyst Rating | The Analyst Target Price has decreased from $186.5 to $181.92. | Sell | |
| 2021-02-04 06:24 EST | News | Jazz Pharma raised at Piper Sandler on GW Pharma deal | N/A | |
| 2021-02-03 12:09 EST | News | Jazz to acquire GW Pharma in cash-and-stock deal valued at $7.2B | N/A | |
| 2021-02-03 12:08 EST | News | Zogenix, Zynerba jump on positive read through from GW Pharma/Jazz (update) | N/A | |
| 2021-02-03 12:08 EST | News | Jazz Pharmaceuticals looked at GW deal for `quite some time,' CNBC says | N/A | |
| 2021-01-29 09:43 EST | Analyst Rating | The Analyst Target Price has increased from $183.13 to $186.5. | Buy | |
| 2021-01-25 09:40 EST | Analyst Rating | The Analyst Target Price has increased from $182.5 to $183.13. | Buy | |
| 2021-01-24 20:54 EST | News | GW Pharma Well Placed For Further Progress In 2021 And Beyond | N/A | |
| 2021-01-15 19:39 EST | News | GW Pharmaceuticals (GWPH) Presents At 39th Annual JPMorgan Virtual Healthcare Conference - Slideshow | N/A | |
| 2021-01-12 17:43 EST | News | GW Pharmaceuticals plc. (GWPH) CEO Justin Gover on 39th Annual JPMorgan Virtual Healthcare Conference - (Transcript) | N/A | |
| 2021-01-12 17:43 EST | News | 39th Annual JPMorgan Virtual Healthcare Conference | N/A | |
| 2021-01-12 09:38 EST | Analyst Rating | The Analyst Target Price has decreased from $182.81 to $182.5. | Neutral | |
| 2021-01-12 02:52 EST | News | GW Pharmaceuticals foresees Q4 revenue above consensus | N/A | |
| 2021-01-06 09:45 EST | Analyst Rating | The Analyst Target Price has increased from $181.63 to $182.81. | Buy | |
| 2021-01-05 13:51 EST | Analyst Rating | The Analyst Target Price has decreased from $182.88 to $181.63. | Neutral | |
| 2021-01-04 13:51 EST | Analyst Rating | The Analyst Target Price has decreased from $184 to $182.88. | Neutral | |
| 2021-01-01 01:59 EST | News | Seeking Alpha Catalyst Watch | N/A | |
| 2020-12-11 16:32 EST | News | GW Pharmaceuticals: The One 'Cannabis Stock' Everyone Should Own | N/A | |
| 2020-12-04 18:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 10:30 EST | News | GW Pharmaceuticals plc (GWPH) CEO Justin Grover presents at Stifel Virtual Healthcare Conference (Transcript) | N/A | |
| 2020-11-19 06:36 EST | News | GW Pharmaceuticals plc (GWPH) CEO Justin Gover presents at Stifel Virtual Healthcare Conference (Transcript) | N/A | |
| 2020-11-12 13:02 EST | News | GW Pharmaceuticals: Buy This Stock With Strong Guidance And A Solid Pipeline | N/A | |
| 2020-11-08 02:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 14:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 22:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 09:59 EST | Analyst Rating | The Analyst Target Price has decreased from $185.81 to $184. | Neutral | |
| 2020-11-05 22:54 EST | News | GW Pharmaceuticals Plc Remains A Solid Growth Story | N/A | |
| 2020-11-05 21:17 EST | Insider Trade | GEOFFREY W DR GUY has directly disposed of 18,000 shares and currently holds 5,501,521 shares. | Sell | |
| 2020-11-05 21:17 EST | Insider Trade | GEOFFREY W DR GUY has directly disposed of 92,724 shares and currently holds 5,519,521 shares. | Sell | |
| 2020-11-05 21:17 EST | Insider Trade | GEOFFREY W DR GUY has directly disposed of 140,040 shares and currently holds 5,612,245 shares. | Sell | |
About GW Pharmaceuticals plc (GWPH):
GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
General
- Name GW Pharmaceuticals plc
- Symbol GWPH
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-General
- Full Time Employees 1,161
- Fiscal Year EndDecember
- IPO Date2013-05-01
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.gwpharm.com
View More
Valuation
- Trailing PE 91.14
- Forward PE 454.55
- Price/Sales (Trailing 12 Mt.) 12.76
- Price/Book (Most Recent Quarter) 9.15
- Enterprise Value Revenue 11.42
- Enterprise Value EBITDA 84.16
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.42
- Next Year EPS Estimate $5.08
- Next Quarter EPS Estimate -$0.36
- Profit Margin -11%
- Operating Margin -10%
- Return on Assets -4%
- Return on Equity -8%
- Revenue 527.2 million
- Earnings Per Share $1.07
- Revenue Per Share $16.84
- Gross Profit 489.67 million
- Quarterly Earnings Growth 35.9%
View More
Highlights
- Market Capitalization 6.48 billion
- EBITDA -214163008
- PEG Ratio 0.37
- Analyst Target Price $204.9
- Book Value Per Share $23.70
View More
Share Statistics
- Shares Outstanding 31.53 million
- Shares Float 30.65 million
- % Held by Insiders 64%
- % Held by Institutions 84.41%
- Shares Short 416741
- Shares Short Prior Month 597624
- Short Ratio 0.25
- Short % of Shares Outstanding 1%
View More
Technicals
- Beta 2
- 52 Week High $216.9
- 52 Week Low $73.52
- 50 Day Moving Average 205.17
- 200 Day Moving Average 136.51
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
GW Pharmaceuticals plc (GWPH) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
GW Pharmaceuticals plc (GWPH) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-16 | $N/A | -$0.08 | -$0.05 | -47.06% |
| 2020-09-30 | 2020-11-03 | $N/A | -$0.03 | -$0.06 | 46.43% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.02 | -$0.04 | 50.12% |
| 2020-03-31 | 2020-05-11 | $120.63 million | -$0.02 | -$0.07 | 71.1% |
| 2019-12-31 | 2020-02-25 | $109.08 million | -$0.07 | -$0.03 | -143.9% |
| 2019-09-30 | 2019-11-05 | $90.97 million | -$0.04 | -$0.06 | 36.71% |
| 2019-06-30 | 2019-08-06 | $72.04 million | -$0.06 | $0.03 | -301.25% |
| 2019-03-31 | 2019-05-06 | $39.25 million | -$0.14 | -$0.14 | 0% |
| 2018-12-31 | 2019-02-26 | $6.65 million | -$2.40 | -$2.90 | 17.24% |
| 2018-09-30 | 2018-11-27 | $-1274007 | -$0.23 | -$0.77 | 70.09% |
| 2018-06-30 | 2018-08-07 | $2.62 million | -$1.26 | -$1.01 | -24.51% |
| 2018-03-31 | 2018-05-08 | $2.39 million | -$3.12 | -$2.61 | -19.54% |
| 2017-12-31 | 2018-02-05 | $7.73 million | -$2.44 | -$2.12 | -14.91% |
| 2017-09-30 | 2017-12-04 | $3.12 million | -$2.18 | -$1.16 | -88.6% |
| 2017-06-30 | 2017-08-07 | $3.3 million | -$2.08 | -$1.07 | -94.56% |
| 2017-03-31 | 2017-05-09 | $2.08 million | -$1.70 | -$0.78 | -117.9% |
| 2016-12-31 | 2017-02-07 | $2.54 million | -$0.78 | -$0.10 | -652.37% |
| 2016-09-30 | 2016-12-05 | $1.98 million | -$0.87 | -$0.84 | -3.46% |
| 2016-06-30 | 2016-08-09 | $2.37 million | -$0.72 | -$0.49 | -46.83% |
| 2016-03-31 | 2016-05-05 | $3.68 million | -$1.11 | -$0.10 | -1041.13% |
| 2015-12-31 | 2016-02-10 | $5.41 million | -$1.18 | -$0.12 | -884.42% |
| 2015-09-30 | 2015-12-07 | $7.06 million | -$0.85 | -$1.37 | 37.96% |
| 2015-06-30 | 2015-08-06 | $14.83 million | -$1.60 | -$1.16 | -37.93% |
| 2015-03-31 | 2015-05-11 | $8.85 million | -$0.58 | -$1.12 | 48.21% |
| 2014-12-31 | 2015-02-04 | $12.41 million | -$0.27 | -$1.25 | 78.4% |
| 2014-09-30 | 2014-12-02 | $10.03 million | $0.03 | -$0.69 | 104.35% |
| 2014-06-30 | 2014-08-06 | $13.66 million | -$0.66 | -$1.08 | 38.89% |
| 2014-03-31 | 2014-05-07 | $12.63 million | -$0.49 | -$0.48 | -2.08% |
| 2013-12-31 | 2014-02-05 | $12.41 million | -$0.31 | -$0.33 | 6.06% |
| 2013-09-30 | 2013-11-19 | $13.48 million | -$0.24 | -$0.29 | 17.24% |
| 2013-06-30 | 2013-08-05 | $11.06 million | -$0.02 | -$0.17 | 88.24% |
GW Pharmaceuticals plc (GWPH) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
GW Pharmaceuticals plc (GWPH) Chart:
GW Pharmaceuticals plc (GWPH) News:
Below you will find a list of latest news for GW Pharmaceuticals plc (GWPH) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
GW Pharmaceuticals plc (GWPH) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
GW Pharmaceuticals plc (GWPH) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320017299/0000899243-20-017299-index.htm |
| 2020-02-04 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1351288/000003877720000025/0000038777-20-000025-index.htm |
| 2019-12-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1351288/000089542119000661/0000895421-19-000661-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1351288/000089542120000121/0000895421-20-000121-index.htm |
| 2019-05-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319011689/0000899243-19-011689-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319012933/0000899243-19-012933-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319012935/0000899243-19-012935-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014050/0000899243-19-014050-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/0000899243-19-014292-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014293/0000899243-19-014293-index.htm |
| 2019-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015229/0000899243-19-015229-index.htm |
| 2019-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015678/0000899243-19-015678-index.htm |
| 2019-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319017352/0000899243-19-017352-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319019500/0000899243-19-019500-index.htm |
| 2019-07-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319019501/0000899243-19-019501-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319021736/0000899243-19-021736-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319022228/0000899243-19-022228-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319027195/0000899243-19-027195-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924319029665/0000899243-19-029665-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320000726/0000899243-20-000726-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320000727/0000899243-20-000727-index.htm |
| 2020-01-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320000728/0000899243-20-000728-index.htm |
| 2020-01-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320001383/0000899243-20-001383-index.htm |
| 2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320003296/0000899243-20-003296-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006327/0000899243-20-006327-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006328/0000899243-20-006328-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006329/0000899243-20-006329-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006331/0000899243-20-006331-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006992/0000899243-20-006992-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006993/0000899243-20-006993-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006995/0000899243-20-006995-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006996/0000899243-20-006996-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006997/0000899243-20-006997-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006998/0000899243-20-006998-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006999/0000899243-20-006999-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320008655/0000899243-20-008655-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320008656/0000899243-20-008656-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/0000899243-20-013766-index.htm |
| 2020-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/0000899243-20-013769-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320014631/0000899243-20-014631-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320014942/0000899243-20-014942-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015687/0000899243-20-015687-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015688/0000899243-20-015688-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015689/0000899243-20-015689-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015690/0000899243-20-015690-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015692/0000899243-20-015692-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015693/0000899243-20-015693-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015694/0000899243-20-015694-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015696/0000899243-20-015696-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015697/0000899243-20-015697-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015699/0000899243-20-015699-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015700/0000899243-20-015700-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015701/0000899243-20-015701-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320015702/0000899243-20-015702-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320016919/0000899243-20-016919-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320017299/0000899243-20-017299-index.htm |
| 2020-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320018765/0000899243-20-018765-index.htm |
| 2020-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320020102/0000899243-20-020102-index.htm |
| 2020-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320021685/0000899243-20-021685-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320022190/0000899243-20-022190-index.htm |
| 2020-09-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320025418/0000899243-20-025418-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320025421/0000899243-20-025421-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320026863/0000899243-20-026863-index.htm |
| 2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030504/0000899243-20-030504-index.htm |
| 2020-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2019-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000114420419023901/0001144204-19-023901-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000114420419030761/0001144204-19-030761-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000114420419030823/0001144204-19-030823-index.htm |
| 2019-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000114420419036142/0001144204-19-036142-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312519214062/0001193125-19-214062-index.htm |
| 2019-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312519251259/0001193125-19-251259-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312519284704/0001193125-19-284704-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520006419/0001193125-20-006419-index.htm |
| 2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520022926/0001193125-20-022926-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520048338/0001193125-20-048338-index.htm |
| 2020-03-27 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1351288/000119312520088901/0001193125-20-088901-index.htm |
| 2020-04-07 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1351288/000119312520100543/0001193125-20-100543-index.htm |
| 2020-05-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1351288/000119312520135013/0001193125-20-135013-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520139403/0001193125-20-139403-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520153190/0001193125-20-153190-index.htm |
| 2020-05-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1351288/000119312520153199/0001193125-20-153199-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520212095/0001193125-20-212095-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520243135/0001193125-20-243135-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1351288/000119312520284523/0001193125-20-284523-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1351288/000142284820000045/0001422848-20-000045-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1351288/000142284920000062/0001422849-20-000062-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1351288/000156459019016648/0001564590-19-016648-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1351288/000156459019030096/0001564590-19-030096-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1351288/000156459019040593/0001564590-19-040593-index.htm |
| 2020-02-27 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1351288/000156459020007319/0001564590-20-007319-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1351288/000156459020024348/0001564590-20-024348-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1351288/000156459020038496/0001564590-20-038496-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1351288/000156459020050655/0001564590-20-050655-index.htm |
GW Pharmaceuticals plc (GWPH) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GW Pharmaceuticals plc (GWPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 64%Institutional Ownership: 8441%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-07-06 | Douglas B. Snyder | Chief Legal Officer | Sell | 9,804.00 | 10.50 | 102,942.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320018765/0000899243-20-018765-index.htm |
| 2019-07-10 | William A. Waldegrave | Director | Sell | 3,576.00 | 15.00 | 53,640.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319019501/0000899243-19-019501-index.htm |
| 2019-05-07 | Adam D. George | Secretary | Sell | 258,324.00 | 16.10 | 4,159,016.40 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319012935/0000899243-19-012935-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 10,788.00 | 15.19 | 163,869.72 | 106,548.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-05-24 | James Noble | Director | Buy | 68,117.00 | 4.86 | 331,327.90 | 110,096.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 31,368.00 | 15.12 | 474,284.16 | 117,336.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2020-08-10 | Douglas B. Snyder | Chief Legal Officer | Buy | 122,364.00 | 0.00 | 159.07 | 122,364.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320022190/0000899243-20-022190-index.htm |
| 2020-05-18 | Volker Knappertz | Chief Medical Officer | Buy | 121,476.00 | 0.00 | 145.77 | 139,092.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/0000899243-20-013769-index.htm |
| 2020-05-18 | Scott M. Giacobello | Chief Financial Officer | Buy | 108,468.00 | 0.00 | 130.16 | 140,742.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/0000899243-20-013766-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 12,048.00 | 15.03 | 181,081.44 | 148,704.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 145,164.00 | 14.96 | 2,171,653.44 | 160,752.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2020-03-02 | CATHERINE J MACKEY | Director | Sell | 1,356.00 | 8.35 | 11,322.60 | 16,392.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006999/0000899243-20-006999-index.htm |
| 2020-03-02 | Alicia Secor | Director | Sell | 1,296.00 | 8.34 | 10,808.64 | 16,440.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006996/0000899243-20-006996-index.htm |
| 2020-03-02 | Cabot Brown | Director | Sell | 3,144.00 | 8.24 | 25,906.56 | 17,088.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006997/0000899243-20-006997-index.htm |
| 2020-01-03 | Alicia Secor | Director | Sell | 1,536.00 | 8.53 | 13,102.08 | 17,736.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320000727/0000899243-20-000727-index.htm |
| 2020-01-03 | CATHERINE J MACKEY | Director | Sell | 1,536.00 | 8.54 | 13,117.44 | 17,748.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320000726/0000899243-20-000726-index.htm |
| 2020-01-03 | Cabot Brown | Director | Sell | 3,576.00 | 8.58 | 30,682.08 | 20,232.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320000728/0000899243-20-000728-index.htm |
| 2019-05-07 | Christopher J. Tovey | Chief Operating Officer | Buy | 200,736.00 | 0.00 | 260.96 | 203,239.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319012933/0000899243-19-012933-index.htm |
| 2019-05-07 | Christopher J. Tovey | Chief Operating Officer | Sell | 200,736.00 | 16.14 | 3,239,879.04 | 2,503.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319012933/0000899243-19-012933-index.htm |
| 2019-05-15 | Christopher J. Tovey | Chief Operating Officer | Sell | 1,200.00 | 15.01 | 18,012.00 | 2,503.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014050/0000899243-19-014050-index.htm |
| 2019-06-03 | Christopher J. Tovey | Chief Operating Officer | Sell | 64,800.00 | 14.61 | 946,728.00 | 2,503.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015678/0000899243-19-015678-index.htm |
| 2019-05-07 | Adam D. George | Secretary | Buy | 258,324.00 | 0.00 | 335.82 | 268,324.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319012935/0000899243-19-012935-index.htm |
| 2020-09-30 | Douglas B. Snyder | Chief Legal Officer | Sell | 14,400.00 | 8.13 | 117,072.00 | 26,904.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320026863/0000899243-20-026863-index.htm |
| 2019-05-24 | James Noble | Director | Sell | 13,800.00 | 15.58 | 215,004.00 | 27,500.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2019-05-28 | Darren S Cline | U.S. Chief Commercial Officer | Buy | 29,424.00 | 0.00 | 38.25 | 29,424.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015229/0000899243-19-015229-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 208,260.00 | 14.88 | 3,098,908.80 | 305,916.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-07-10 | William A. Waldegrave | Director | Buy | 3,576.00 | 0.00 | 4.65 | 3,576.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319019501/0000899243-19-019501-index.htm |
| 2019-05-15 | Christopher J. Tovey | Chief Operating Officer | Buy | 1,200.00 | 3.29 | 3,948.00 | 3,703.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014050/0000899243-19-014050-index.htm |
| 2019-05-24 | James Noble | Director | Sell | 3,600.00 | 15.49 | 55,764.00 | 41,300.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2020-08-11 | Douglas B. Snyder | Chief Legal Officer | Sell | 24,000.00 | 9.40 | 225,600.00 | 41,304.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320022190/0000899243-20-022190-index.htm |
| 2020-11-04 | Volker Knappertz | Chief Medical Officer | Sell | 6,000.00 | 9.17 | 55,020.00 | 41,940.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030504/0000899243-20-030504-index.htm |
| 2019-05-24 | James Noble | Director | Buy | 14,479.00 | 0.00 | 18.82 | 41,979.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2019-05-24 | James Noble | Director | Sell | 10,200.00 | 15.32 | 156,264.00 | 44,900.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2020-06-15 | Justin D. Gover | Chief Executive Officer | Buy | 4,164.00 | 0.00 | 5.41 | 458,129.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320016919/0000899243-20-016919-index.htm |
| 2020-08-04 | Volker Knappertz | Chief Medical Officer | Sell | 6,000.00 | 11.11 | 66,660.00 | 47,940.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320021685/0000899243-20-021685-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Buy | 403,804.00 | 0.00 | 524.95 | 510,352.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 65,268.00 | 14.80 | 965,966.40 | 514,176.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2020-07-20 | Volker Knappertz | Chief Medical Officer | Sell | 6,000.00 | 11.42 | 68,520.00 | 53,940.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320020102/0000899243-20-020102-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Sell | 6,012.00 | 15.49 | 93,125.88 | 541,541.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Sell | 19,284.00 | 15.43 | 297,552.12 | 547,553.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2020-05-29 | GEOFFREY W DR GUY | Executive Chairman | Sell | 600,000.00 | 10.24 | 6,144,000.00 | 5,501,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320014942/0000899243-20-014942-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Sell | 18,000.00 | 8.59 | 154,620.00 | 5,501,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2019-05-24 | James Noble | Director | Sell | 41,796.00 | 15.26 | 637,806.96 | 55,100.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 9,732.00 | 0.00 | 12.65 | 5,511,253.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-02-26 | Justin D. Gover | Chief Executive Officer | Sell | 876.00 | 9.21 | 8,067.96 | 551,525.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006328/0000899243-20-006328-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Sell | 92,724.00 | 8.54 | 791,862.96 | 5,519,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-02-26 | Justin D. Gover | Chief Executive Officer | Sell | 1,644.00 | 9.17 | 15,075.48 | 552,401.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006328/0000899243-20-006328-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 25,913.00 | 0.00 | 33.69 | 5,537,166.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-02-26 | Justin D. Gover | Chief Executive Officer | Sell | 9,480.00 | 9.01 | 85,414.80 | 554,045.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006328/0000899243-20-006328-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 15,336.00 | 0.00 | 19.94 | 5,552,502.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 15,336.00 | 0.00 | 19.94 | 5,567,838.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2019-06-14 | Justin D. Gover | Chief Executive Officer | Buy | 16,656.00 | 0.00 | 21.65 | 558,197.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319017352/0000899243-19-017352-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Sell | 140,040.00 | 8.48 | 1,187,539.20 | 5,612,245.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2019-12-17 | Justin D. Gover | Chief Executive Officer | Sell | 5,340.00 | 9.17 | 48,967.80 | 563,525.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319029665/0000899243-19-029665-index.htm |
| 2020-02-03 | Justin D. Gover | Chief Executive Officer | Sell | 19,548.00 | 9.71 | 189,811.08 | 563,525.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320003296/0000899243-20-003296-index.htm |
| 2020-03-02 | Justin D. Gover | Chief Executive Officer | Sell | 8,400.00 | 8.40 | 70,560.00 | 566,513.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006995/0000899243-20-006995-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Sell | 40,728.00 | 15.35 | 625,174.80 | 566,837.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2019-12-17 | Justin D. Gover | Chief Executive Officer | Buy | 10,668.00 | 0.00 | 13.87 | 568,865.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319029665/0000899243-19-029665-index.htm |
| 2020-03-02 | Justin D. Gover | Chief Executive Officer | Sell | 24,456.00 | 8.31 | 203,229.36 | 574,913.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006995/0000899243-20-006995-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Sell | 56,388.00 | 8.37 | 471,967.56 | 5,752,285.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 204,552.00 | 0.00 | 265.92 | 5,772,390.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 9,262.00 | 0.00 | 12.04 | 5,781,652.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 81,156.00 | 14.70 | 1,192,993.20 | 579,444.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 16,317.00 | 0.00 | 21.21 | 5,797,969.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-11-03 | GEOFFREY W DR GUY | Executive Chairman | Buy | 10,704.00 | 0.00 | 13.92 | 5,808,673.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320030508/0000899243-20-030508-index.htm |
| 2020-03-02 | Justin D. Gover | Chief Executive Officer | Buy | 30,334.00 | 0.00 | 39.43 | 581,859.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006995/0000899243-20-006995-index.htm |
| 2020-02-03 | Justin D. Gover | Chief Executive Officer | Sell | 110,964.00 | 9.63 | 1,068,583.32 | 583,073.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320003296/0000899243-20-003296-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Buy | 75,369.00 | 10.61 | 799,665.09 | 585,721.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2020-03-02 | Justin D. Gover | Chief Executive Officer | Buy | 17,510.00 | 0.00 | 22.76 | 599,369.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006995/0000899243-20-006995-index.htm |
| 2020-06-17 | Volker Knappertz | Chief Medical Officer | Sell | 18,000.00 | 10.35 | 186,300.00 | 59,940.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320017299/0000899243-20-017299-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Sell | 56,736.00 | 15.25 | 865,224.00 | 607,565.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2020-05-29 | GEOFFREY W DR GUY | Executive Chairman | Sell | 120,000.00 | 10.27 | 1,232,400.00 | 6,101,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320014942/0000899243-20-014942-index.htm |
| 2020-03-13 | GEOFFREY W DR GUY | Executive Chairman | Sell | 600,000.00 | 6.63 | 3,978,000.00 | 6,221,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320008655/0000899243-20-008655-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Sell | 117,876.00 | 14.63 | 1,724,525.88 | 660,600.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Sell | 26,784.00 | 15.17 | 406,313.28 | 664,301.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2020-03-02 | Douglas B. Snyder | Chief Legal Officer | Sell | 2,568.00 | 8.32 | 21,365.76 | 67,296.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006998/0000899243-20-006998-index.htm |
| 2019-06-03 | Christopher J. Tovey | Chief Operating Officer | Buy | 64,800.00 | 3.24 | 209,952.00 | 67,303.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015678/0000899243-19-015678-index.htm |
| 2020-01-15 | GEOFFREY W DR GUY | Executive Chairman | Sell | 600,000.00 | 9.42 | 5,652,000.00 | 6,821,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320001383/0000899243-20-001383-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Sell | 52,680.00 | 15.08 | 794,414.40 | 691,085.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2020-02-03 | Justin D. Gover | Chief Executive Officer | Sell | 71,712.00 | 9.57 | 686,283.84 | 694,037.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320003296/0000899243-20-003296-index.htm |
| 2020-02-26 | Douglas B. Snyder | Chief Legal Officer | Sell | 240.00 | 9.20 | 2,208.00 | 69,864.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006331/0000899243-20-006331-index.htm |
| 2020-02-26 | Douglas B. Snyder | Chief Legal Officer | Sell | 3,636.00 | 9.17 | 33,342.12 | 70,104.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006331/0000899243-20-006331-index.htm |
| 2020-05-28 | Darren S Cline | U.S. Chief Commercial Officer | Buy | 7,356.00 | 0.00 | 8.83 | 7,356.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320014631/0000899243-20-014631-index.htm |
| 2019-08-19 | Douglas B. Snyder | Chief Legal Officer | Sell | 5,424.00 | 13.04 | 70,728.96 | 73,740.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319022228/0000899243-19-022228-index.htm |
| 2020-01-15 | GEOFFREY W DR GUY | Executive Chairman | Sell | 300,000.00 | 9.47 | 2,841,000.00 | 7,421,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320001383/0000899243-20-001383-index.htm |
| 2019-05-28 | Justin D. Gover | Chief Executive Officer | Buy | 202,224.00 | 0.00 | 262.89 | 743,765.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015228/0000899243-19-015228-index.htm |
| 2020-08-10 | Douglas B. Snyder | Chief Legal Officer | Buy | 9,180.00 | 0.00 | 11.93 | 74,484.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320022190/0000899243-20-022190-index.htm |
| 2020-02-03 | Justin D. Gover | Chief Executive Officer | Buy | 202,224.00 | 0.00 | 262.89 | 765,749.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320003296/0000899243-20-003296-index.htm |
| 2019-11-11 | GEOFFREY W DR GUY | Executive Chairman | Sell | 420,000.00 | 9.33 | 3,918,600.00 | 7,721,521.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319027195/0000899243-19-027195-index.htm |
| 2019-05-10 | Julian S Gangolli | President, North America | Buy | 192,755.00 | 3.72 | 717,048.60 | 778,476.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319013509/0000899243-19-013509-index.htm |
| 2019-05-15 | Volker Knappertz | Chief Medical Officer | Sell | 4,296.00 | 14.63 | 62,850.48 | 77,940.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320017299/0000899243-20-017299-index.htm |
| 2019-08-12 | Douglas B. Snyder | Chief Legal Officer | Sell | 3,756.00 | 13.88 | 52,133.28 | 79,164.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319021736/0000899243-19-021736-index.htm |
| 2020-03-02 | Volker Knappertz | Chief Medical Officer | Sell | 3,420.00 | 8.32 | 28,454.40 | 79,392.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006993/0000899243-20-006993-index.htm |
| 2020-03-02 | Scott M. Giacobello | Chief Financial Officer | Sell | 2,220.00 | 8.34 | 18,514.80 | 81,024.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006992/0000899243-20-006992-index.htm |
| 2020-02-26 | Volker Knappertz | Chief Medical Officer | Sell | 180.00 | 9.26 | 1,666.80 | 82,812.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006329/0000899243-20-006329-index.htm |
| 2019-07-09 | Douglas B. Snyder | Chief Legal Officer | Sell | 4,968.00 | 14.42 | 71,638.56 | 82,920.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319019500/0000899243-19-019500-index.htm |
| 2020-02-26 | Volker Knappertz | Chief Medical Officer | Sell | 2,832.00 | 9.17 | 25,969.44 | 82,992.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006329/0000899243-20-006329-index.htm |
| 2020-02-26 | Scott M. Giacobello | Chief Financial Officer | Sell | 228.00 | 9.17 | 2,090.76 | 83,244.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006327/0000899243-20-006327-index.htm |
| 2020-02-26 | Scott M. Giacobello | Chief Financial Officer | Sell | 3,624.00 | 9.17 | 33,232.08 | 83,472.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320006327/0000899243-20-006327-index.htm |
| 2019-05-20 | Volker Knappertz | Chief Medical Officer | Sell | 6,312.00 | 14.76 | 93,165.12 | 85,824.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/0000899243-19-014292-index.htm |
| 2019-05-20 | Scott M. Giacobello | Chief Financial Officer | Sell | 4,224.00 | 14.52 | 61,332.48 | 87,096.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014293/0000899243-19-014293-index.htm |
| 2020-03-13 | Scott M. Giacobello | Chief Financial Officer | Buy | 7,200.00 | 6.80 | 48,960.00 | 88,224.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320008656/0000899243-20-008656-index.htm |
| 2019-05-18 | Scott M. Giacobello | Chief Financial Officer | Buy | 8,136.00 | 0.00 | 10.58 | 91,320.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014293/0000899243-19-014293-index.htm |
| 2019-05-20 | Volker Knappertz | Chief Medical Officer | Sell | 5,832.00 | 14.52 | 84,680.64 | 92,136.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/0000899243-19-014292-index.htm |
| 2020-05-18 | Volker Knappertz | Chief Medical Officer | Buy | 12,144.00 | 0.00 | 14.57 | 92,556.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320013769/0000899243-20-013769-index.htm |
| 2020-05-18 | Scott M. Giacobello | Chief Financial Officer | Buy | 8,136.00 | 0.00 | 9.76 | 95,094.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924320013766/0000899243-20-013766-index.htm |
| 2019-05-24 | James Noble | Director | Sell | 13,200.00 | 15.17 | 200,244.00 | 96,896.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319015096/0000899243-19-015096-index.htm |
| 2019-05-18 | Volker Knappertz | Chief Medical Officer | Buy | 12,144.00 | 0.00 | 15.79 | 97,968.00 | https://www.sec.gov/Archives/edgar/data/1351288/000089924319014292/0000899243-19-014292-index.htm |